PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Experimental Reproductive Medicine10.5653/cerm.2020.041122021483245-254Alteration of TGFB1, GDF9, and BMPR2 gene expression in preantral follicles of an estradiol valerate-induced polycystic ovary mouse model can lead to anovulation, polycystic morphology, obesity, and absence of hyperandrogenismReza Asghari, Vahid Shokri-Asl, Hanieh Rezaei, Mahmood Tavallaie, Mostafa Khafaei, Amir Abdolmaleki, Abbas Majdi Seghinsarahttp://ecerm.org/upload/pdf/cerm-2020-04112.pdf, http://ecerm.org/journal/view.php?doi=10.5653/cerm.2020.04112, http://ecerm.org/upload/pdf/cerm-2020-04112.pdf
Current Management of Polycystic Ovary Syndrome10.1017/cbo9781107478343.0132010125-142Treatment of hyperandrogenism in polycystic ovary syndromeAlison M Laytonhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/71A859D3699F7DCAF1AC89DC6C855891
Toxicology Letters10.1016/j.toxlet.2009.06.8282009189S150Estradiol valerate-induced atypical endometrial hyperplasia in experimental polycystic ovaryHabib Allah Shojaei Saadi, Mohammad Amin Rezvanfar, Mohammad Abdollahihttps://api.elsevier.com/content/article/PII:S0378427409011424?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0378427409011424?httpAccept=text/plain
Neuropeptides10.1016/j.npep.2020.102026202080102026Neuropeptide galanin and its effects on metabolic and reproductive disturbances in female rats with estradiol valerate (EV) - Induced polycystic ovary syndrome (PCOS)Farahnaz Azin, Homayoun Khazalihttps://api.elsevier.com/content/article/PII:S0143417919301064?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0143417919301064?httpAccept=text/plain
Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health10.1007/978-3-030-63650-0_3202125-31Toward Adolescent Prevention of Adult Anovulation in Polycystic Ovary SyndromeFrancis de Zegher, Lourdes Ibáñezhttps://link.springer.com/content/pdf/10.1007/978-3-030-63650-0_3
Medicina10.3390/medicina560301002020563100Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary MorphologyAbhaya Krishnan, Sridhar Muthusami, Loganayaki Periyasamy, Jone A. Stanley, Vasudevan Gopalakrishnan, Ilangovan Ramachandranhttps://www.mdpi.com/1648-9144/56/3/100/pdf
Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health10.1007/978-3-030-63650-0_120211-12The Brain Phenotype in Polycystic Ovary Syndrome (PCOS): Androgens, Anovulation, and GenderSarah L. Bergahttps://link.springer.com/content/pdf/10.1007/978-3-030-63650-0_1
Biochemical and Biophysical Research Communications10.1016/j.bbrc.2017.01.05720174842461-466The effects of 6-Gingerol on reproductive improvement, liver functioning and Cyclooxygenase-2 gene expression in estradiol valerate – Induced polycystic ovary syndrome in Wistar ratsParisa Sadat Pournaderi, Parichehreh Yaghmaei, Hamidreza Khodaei, Zahra Noormohammadi, Seyed Hossein Hejazihttps://api.elsevier.com/content/article/PII:S0006291X17300918?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0006291X17300918?httpAccept=text/plain
Polycystic Ovary Syndrome10.1017/9781108989831.0162022150-161The Treatment of Obesity in Polycystic Ovary SyndromeHarry Frydenberghttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/70FF6E7D8426EEDEC9608FD0068EB372
Steroids10.1016/s0039-128x(97)89519-019976211728Mechanisms of anovulation in polycystic ovary syndromehttps://api.elsevier.com/content/article/PII:S0039128X97895190?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0039128X97895190?httpAccept=text/plain